نتائج البحث - Emmanuel Krupka

  • يعرض 1 - 3 نتائج من 3
تنقيح النتائج
  1. 1

    A first‐in‐human, single and multiple dose study of lunsekimig, a novel anti‐TSLP/anti‐IL‐13 NANOBODY® compound, in healthy volunteers حسب Annemie Deiteren, Lieselot Bontinck, Griet Conickx, Marie Vigan, Nele Dervaux, Matthieu Gassiot, Selcuk Bas, Benjamin Suratt, Heribert Staudinger, Emmanuel Krupka

    الحاوية / القاعدة Clinical and Translational Science (2024-06-01)
    احصل على النص الكامل
    مقال


  2. 2

    A phase I trial assessing the safety, pharmacokinetics, cerebrospinal fluid penetrance, and food effect of BTK inhibitor tolebrutinib in healthy volunteers حسب Marie‐José Cabanis, Olivier Nicolas, Olivier Vitse, Christelle Jan, Priscilla Brun, Patrick Soubayrol, William B. Smith, Timothy J. Turner, Emmanuel Krupka

    الحاوية / القاعدة Clinical and Translational Science (2024-02-01)
    احصل على النص الكامل
    مقال


  3. 3

    Safety, pharmacokinetics, and target engagement of a brain penetrant RIPK1 inhibitor, SAR443820 (DNL788), in healthy adult participants حسب Agnes Hincelin‐Mery, Xavier Nicolas, Cathy Cantalloube, Robert Pomponio, Pascale Lewanczyk, Myriam Benamor, Dimitry Ofengeim, Emmanuel Krupka, Jennifer Hsiao‐Nakamoto, Amy Eastenson, Nazem Atassi

    الحاوية / القاعدة Clinical and Translational Science (2024-01-01)
    احصل على النص الكامل
    مقال


أدوات البحث: